AR and triple-negative breast carcinoma: Studies report over expression of the androgen receptor as a reason for chemotherapy resistance, contributes uncontrolled cell proliferation in triple negative breast cancer patients.27 FOXA1 is an inhibitor of AR signaling by detecting it is binding to the cells, whose activity completely overlaps estrogen receptor binding site in an AR positive cells lines and cause tamoxifen resistance.